UBS Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.28M | Buy |
|
|||||
|
2025
Q2 | $755K | Sell |
|
|||||
|
2025
Q1 | $1.09M | Buy |
|
|||||
|
2024
Q4 | $1.95M | Buy |
|
|||||
|
2024
Q3 | $1.31M | Buy |
|
|||||
|
2024
Q2 | $1.14M | Sell |
|
|||||
|
2024
Q1 | $3.94M | Buy |
|
|||||
|
2023
Q4 | $3.1M | Buy |
|
|||||
|
2023
Q3 | $1.03M | Sell |
|
|||||
|
2023
Q2 | $2.02M | Buy |
|
|||||
|
2023
Q1 | $1.8M | Buy |
|
|||||
|
2022
Q4 | $1.24M | Buy |
|
|||||
|
2022
Q3 | $1.04M | Sell |
|
|||||
|
2022
Q2 | $1.98M | Sell |
|
|||||
|
2022
Q1 | $6.12M | Buy |
|
|||||
|
2021
Q4 | $235K | Sell |
|
|||||
|
2021
Q3 | $731K | Buy |
|
|||||
|
2021
Q2 | $194K | Sell |
|
|||||
|
2021
Q1 | $1.27M | Buy |
|
|||||
|
2020
Q4 | $10K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $92K | Sell |
|
|||||
|
2020
Q1 | $292K | Sell |
|
|||||
|
2019
Q4 | $433K | Buy |
|
|||||
|
2019
Q3 | $226K | Buy |
|
|||||
|
2019
Q2 | $46K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $145K | Buy |
|
|||||
|
2018
Q3 | $32K | Buy |
|
|||||
|
2018
Q2 | $7K | Buy |
|